Dr. Kaida’s research interests pertain to understanding the impact of expanding access to HIV prevention and treatment services on reproductive intentions, behaviours, and outcomes of HIV-affected couples in high HIV prevalence settings. Antiretroviral treatment (ART) dramatically reduces the risks of sexual and perinatal HIV transmission, thereby changing the landscape of reproduction for HIV-affected couples. Recent successes with microbicides and the potential of antiretroviral pre-exposure prophylaxis (PrEP) may offer additional protection for HIV-affected couples wishing to conceive. In collaboration with Ugandan and American investigators, Dr. Kaida is investigating the prevalence and predictors of fertility desire and pregnancy among HIV-positive women and men on ART who report sero-discordant partners. This study constitutes a critical step towards designing bio-behavioural reproductive counselling interventions to reduce sexual HIV transmission in the context of desired conception. In collaboration with South African investigators, Dr. Kaida is investigating the impact of HIV prevention and treatment services of maternal and adolescent health outcomes and HIV transmission in Soweto. Dr. Kaida is also engaged in research aimed at describing the reproductive trends and needs of HIV-positive women in Canada and the interplay between pregnancy, antiretroviral adherence, and HIV disease progression
